Jamil Kendall1, Christopher E Pelt2, Benjamin Imlay3, Patrick Yep3, Kyle Mullen3, Ryland Kagan1. 1. Department of Orthopaedics and Rehabilitation, Oregon Health and Science University, Portland, OR, USA. 2. Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, UT, USA. 3. American Academy of Orthopaedic Surgeons, Registries and Data Science Department, Rosemont, IL, USA.
Abstract
BACKGROUND: Highly cross-linked polyethylene (HXLPE) can improve wear properties in TKA, but it can also lead to decreased mechanical properties. Antioxidants were added to HXLPE to improve its mechanical properties while retaining the improved wear characteristics. However, it remains unclear whether these modifications to conventional polytheylene used in TKA have resulted in a change in the revision risk. QUESTIONS/PURPOSES: We used American Joint Replacement Registry data to ask: (1) Is there a difference in all-cause revision in patients who underwent TKA using HXLPE with or without an antioxidant doping compared with conventional polyethylene? (2) Is there a difference in revision for aseptic failure in patients who underwent TKA using HXLPE with or without an antioxidant doping compared with conventional polyethylene? METHODS: We analyzed American Joint Replacement Registry data from 2012 to 2019. We identified 339,366 primary TKAs over the study period in patients older than 65 years and linked procedures to supplemental Centers for Medicare & Medicaid data where available. Patient total number of reported comorbidities, gender, age, region, polyethylene characteristics, procedure dates, and indication for revision were recorded. Median follow-up was 34 months. We compared HXLPE with or without antioxidants to conventional polyethylene. Event-free percent survival curves and Cox proportional hazard regression modeling was used for all-cause revision and revision for aseptic failure. RESULTS: Compared with conventional polyethylene, there was no difference in all-cause revision with HXLPE with an antioxidant (HR 1.06 [95% CI 0.98 to 1.14]; p = 0.13) or HXLPE without an antioxidant (HR 1.04 [95% CI 0.97 to 1.11]; p = 0.28). Compared with conventional polyethylene, there was no difference in revision for aseptic failure with HXLPE with an antioxidant (HR 1.07 [95% CI 0.99 to 1.14]; p = 0.08) or HXLPE without an antioxidant (HR 1.03 [95% CI 0.97 to 1.01]; p = 0.30). CONCLUSION: We found no difference in revision risk between HXLPE with or without an antioxidant and conventional polyethylene during this time frame. HXLPE polyethylene, with or without an antioxidant, should not be widely adopted until or unless it is shown to be superior to conventional polyethylene in TKA. LEVEL OF EVIDENCE: Level III, therapeutic study.
BACKGROUND: Highly cross-linked polyethylene (HXLPE) can improve wear properties in TKA, but it can also lead to decreased mechanical properties. Antioxidants were added to HXLPE to improve its mechanical properties while retaining the improved wear characteristics. However, it remains unclear whether these modifications to conventional polytheylene used in TKA have resulted in a change in the revision risk. QUESTIONS/PURPOSES: We used American Joint Replacement Registry data to ask: (1) Is there a difference in all-cause revision in patients who underwent TKA using HXLPE with or without an antioxidant doping compared with conventional polyethylene? (2) Is there a difference in revision for aseptic failure in patients who underwent TKA using HXLPE with or without an antioxidant doping compared with conventional polyethylene? METHODS: We analyzed American Joint Replacement Registry data from 2012 to 2019. We identified 339,366 primary TKAs over the study period in patients older than 65 years and linked procedures to supplemental Centers for Medicare & Medicaid data where available. Patient total number of reported comorbidities, gender, age, region, polyethylene characteristics, procedure dates, and indication for revision were recorded. Median follow-up was 34 months. We compared HXLPE with or without antioxidants to conventional polyethylene. Event-free percent survival curves and Cox proportional hazard regression modeling was used for all-cause revision and revision for aseptic failure. RESULTS: Compared with conventional polyethylene, there was no difference in all-cause revision with HXLPE with an antioxidant (HR 1.06 [95% CI 0.98 to 1.14]; p = 0.13) or HXLPE without an antioxidant (HR 1.04 [95% CI 0.97 to 1.11]; p = 0.28). Compared with conventional polyethylene, there was no difference in revision for aseptic failure with HXLPE with an antioxidant (HR 1.07 [95% CI 0.99 to 1.14]; p = 0.08) or HXLPE without an antioxidant (HR 1.03 [95% CI 0.97 to 1.01]; p = 0.30). CONCLUSION: We found no difference in revision risk between HXLPE with or without an antioxidant and conventional polyethylene during this time frame. HXLPE polyethylene, with or without an antioxidant, should not be widely adopted until or unless it is shown to be superior to conventional polyethylene in TKA. LEVEL OF EVIDENCE: Level III, therapeutic study.
Authors: Daniel W MacDonald; Genymphas B Higgs; Antonia F Chen; Arthur L Malkani; Michael A Mont; Steven M Kurtz Journal: J Arthroplasty Date: 2017-09-25 Impact factor: 4.757
Authors: Hannah Spece; Jaclyn T Schachtner; Daniel W MacDonald; Gregg R Klein; Michael A Mont; Gwo-Chin Lee; Steven M Kurtz Journal: J Arthroplasty Date: 2019-07-18 Impact factor: 4.757
Authors: Kimberly R Porter; Richard L Illgen; Bryan D Springer; Kevin J Bozic; Scott M Sporer; James I Huddleston; David G Lewallen; James A Browne Journal: J Am Acad Orthop Surg Date: 2022-01-01 Impact factor: 3.020
Authors: Richard N de Steiger; Orhun Muratoglu; Michelle Lorimer; Alana R Cuthbert; Stephen E Graves Journal: Acta Orthop Date: 2015-06-28 Impact factor: 3.717